期刊文献+

汉族人群人类血小板抗原-1系统a/b/x等位基因多态性调查 被引量:2

Distribution of HPA-1a/b/x allele polymorphism in Chinese Hans
原文传递
导出
摘要 目的:调查HPA-1抗原系统a/b/x等位基因在汉族人群中的多态性分布。方法:利用聚合酶链反应-序列特异引物技术(PCR-SSP)技术对1000例中国无关健康汉族人群样本进行HPA-1抗原系统等位基因分型,随机抽取部分样本进行测序验证。结果:本次调查共检测到HPA-1a/a基因型988个,HPA-1a/b基因型12个,未检测到HPA-1x等位基因。结论:HPA-1抗原系统在中国汉族人群中以HPA-1a等位基因为主(99.4%),HPA-1b分布频率较低(0.6%)。目前国内尚未发现HPA-1x等位基因,有必要进一步扩大样本对不同地区、不同民族进行多态性调查。 Objective:To investigate the polymorphism of HPA-1 antigen system a/b/x alleles in Chinese Han population.Method:HPA-1 antigen system alleles of 1000 samples from unrelated healthy Chinese Han population were genotyped by PCR-SSP(Polymerase Chain Reaction-Sequence Specific Primed),part of samples were selected randomly and sequenced for confirmation.Result:988 genotypes of a/a and 12 of a/b alleles in HPA-1 antigen system were identified,none of HPA-1x allele were found.Conclusion:Of the identified HPA-1 antigen system polymorphisms,HPA-1a allele is primary in Chinese Han population(the frequency is 99.4%),the frequency of HPA-1b polymorphism distribution is low(0.6%).In the present study,none of HPA-1x alleles have identified in China,further investigation on polymorphism distribution in various areas and populations is needed with larger samples.
出处 《临床血液学杂志(输血与检验)》 CAS 2010年第3期321-323,共3页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
基金 上海市自然科学基金资助课题(No:05ZR14107)
关键词 中国汉族人群 HPA-1 等位基因 多态性 Chinese Hans HPA-1 allele polymorphism
  • 相关文献

参考文献8

  • 1SANTOSO S, KROLL H, ANDREI SELMER C, et al. A naturally occurring Leu33Val mutation in β3-in tegrin impairs the HPA-la epitope: the third allele of HPA-1[J].Transfusion,2006,46: 790-799.
  • 2张晰,冯明亮,沈彤,沈伟,王健莲,刘达庄.单采血小板输血反应调查及其输注无效解决策略[J].中国输血杂志,2008,21(6):455-457. 被引量:32
  • 3刘达庄,朱俊,朱自严,沈伟,王健莲,向东,张雄民,陈和平,陆震宇,郭忠慧,李志强,金麒英,方勇,姚顶根,胡宁克,邹纬,鲍聿炜,马淑芬,刘宇宁,李海伦,孙伟文,马惠荣.免疫性输血反应的调查及预防研究[J].中国输血杂志,2002,15(3):159-161. 被引量:95
  • 4ALLEN D L,SAMOL J,BENJAMIN S,et al. Survey of the use and clinical effectiveness of HPA-1a/5b- negative platelet concentrates in proven or suspected platelet alloimmunization [J]. Transfusion Medicine, 2004, 14:409-417.
  • 5SHIBATA Y, MIYAJI T, ICHIKAWA Y, et al. A new platelet antigen system, Yuk^a/Yuk^b[J].Vox Sang, 1986, 51:334-336.
  • 6MUELLER-ECKHARDT KIEFEL V, GRUBERT A,KROLL H,et al. 348 cases of suspected neonatal alloimmune thrombocytopenia[J].Lancet, 1989, 8634:363-366.
  • 7WILLIAMSON L M, HACKETT G, RENNIE J, et al. The natural history of fetomaternal alloimmunization to the plateletspecific antigen HPA-1a (PIA, Zwa) as determined by antenatal screening [J]. Blood, 1998, 92:2280- 2287.
  • 8NEWMAN P J,DERBES R S,ASTER R H. The hu man platelet alloantigens, PIA1 and PIA2 , are associ ated with a leueine33/ proline33 amino acid polymor phism in membrane glycoprotein Ⅲa, and are distin guishable by DNA typing[J]. J Clin Invest, 1989 83: 1778-1781.

二级参考文献14

  • 1刘达庄,陆萍,王健莲,包于勤,吴国光.血小板同种抗体与输血效果[J].中国输血杂志,1993,6(2):76-77. 被引量:29
  • 2刘达庄,包于勤.简易致敏红细胞血小板血清学技术的研究和应用[J].中华血液学杂志,1993,14(12):642-644. 被引量:37
  • 3Novotny VMJ. Prevention and management of platelet transfusion refractoriness[ J]. Vox Sang, 1999, 76( 1 ) : 1
  • 4Haddad SA, Lichtiger B, Klein HG, et al. In vivo efficacy of shipped HLA-matched platelets [ J ]. Transfusion, 2006, 46 ( 8 ) : 1306-1310
  • 5Sukati H, Bessos H, Barker RN, et al. Characterization of the allore.active helper T-cell response to the platelet membrane glycoprotein IIIa (integrin-beta3) in human platelet antigen-1 a alloimmunised human platelet antigen-lblb women [ J]. Transfusion, 2005, 45(7) :1165-77
  • 6Feng ML, Liu DZ, Shen W, et al. Establishment ofa HPA-I-to- 16-typed platelet donor registry in China[ J]. Trans Med, 2006, 16(10) :369-374
  • 7Murphy MF, Brown M, Carryington P, et al. Guidelines for the use of platelet transfusions[ J]. Brit J Haematol, 2003, 122( 1 ) : 10-23
  • 8Barocei S, Valente U, Nocera A, et al. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation[ J]. Clin Transplant ,2007,21 ( 1 ) :47-56
  • 9Ringwald J, Schroth M, Faschingbauer F, et al. Intrauterine use of hyperconcentrated platelet concentrates collected with Trima Accel in a case of neonatal alloimmune thrombocytopenia[ J]. Transfusion, 2007, 47(8) :1488-1493
  • 10Zimmermann R, Wittmanm G, Zingsem J, et al. Antibodies to private and public HLA class I epitopes in platelet recipients[J]. Transfusion, 1999, 39:772-780

共引文献125

同被引文献48

  • 1田径.新生儿同族免疫性血小板减少性紫癜1例[J].咸宁学院学报(医学版),2006,20(3):189-189. 被引量:1
  • 2温树勤,王桂君,王爱娟.新生儿同族免疫性血小板减少性紫癜3例分析[J].中国误诊学杂志,2007,7(2):348-349. 被引量:2
  • 3胡翊群,夏文权,王鸿利,BoenlenF.双血小板抗原型不合引起的母婴同种免疫性血小板减少症[J].上海医学,1997,20(2):84-86. 被引量:2
  • 4Boersma E, Harrington RA, Moliterno DJ, et al. platelet glycoprotein iib/iiia inhibitors in acute coronary major randomised clinical trials[J] 198 syndromes : a meta - analysis of all Lancet, 2002, 359(9302):189-.
  • 5James S, Akerblom A,Cannon CP,et al. comparison of ticagrelor, the first reversible oral p2y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the platelet inhibition and patient outcomes (plato) trial[ J]. Am Heart J, 2009, 157 (4) :599 - 605.
  • 6Tsimikas S. Drug - eluting stents and late adverse clinical outcomes lessons learned, lessons awaited [ J ]. J Am Coil Cardiol, 2006,47 (10) :2112 -2115.
  • 7Dangas GD, Caixeta A, Mehran R, et al. frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction[ J]. Circulation, 2011, 123 ( 16 ) : 1745 - 1756.
  • 8Kimura T, Morimoto T, Kozuma K,et al. Comparisons of baseline demographics,clinical presentation, and long - term outcome among patients with early,late, and very late stent thrombosis of sirolimus -eluting stents: observations from the Registry of Stent Thrombosis for Review and Reevaluation(RESTART) [ J]. Circulation, 2010,122 ( 1 ) : 52 -61.
  • 9Gurbel PA,Bliden KP, Butler K, et al. randomized double - blind assessment of the onset and offset of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the onset/offset study [ J ]. Circulation, 2009, 120 (25) :2577 - 2585.
  • 10Gurbel PA,Bliden KP, Butler K, et al. response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the respond study[J]. Circulation, 2010, 121 (10) :1188 -1199.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部